Summary:
Click image to enlargeA Phase 2, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of LX9211 in the Treatment of Postherpetic Neuralgia (RELIEF-PHN1)
Qualified Participants May Receive:
Compenastion for time and travel of $50 for each completed visit
All study related care at no cos